You are leaving this website and being redirected. The links below are neither owned nor controlled by Jazz. Jazz is not responsible for the content of any third-party sites.
For information for those in the UK click here to view the Defitelio▼(defibrotide) Patient Information Leaflet on the EMC (electronic medicines compendium) website.
For information for those in Northern Ireland click here to view the Defitelio▼(defibrotide) Patient Information Leaflet on the EMC (electronic medicines compendium) website.
For information for those in the Republic of Ireland click here to view the Defitelio▼(defibrotide) Patient Information Leaflet on the EMA (European Medicines Agency) website.
Reporting of side effects
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
ADVERSE EVENTS REPORTING
Adverse events should be reported. For the UK, reporting forms and information can be found at: https://yellowcard.mhra.gov.uk/
For the Republic of Ireland, reporting forms and information can be found at: https://www.hpra.ie/homepage/about-us/report-an-issue
Adverse events should also be reported to Jazz Pharmaceuticals by phone: +44(0) 8081890387 (freephone) or +353 1 968 1631 (Republic of Ireland-charges may apply) or by e-mail to medinfo-uk@jazzpharma.com